Protein Signatures May Yield New Arthritis Strategies

Your molecular makeup, rather than pain symptoms, may someday produce more effective joint-pain treatments.

Doctors have always relied on telltale signs to diagnosis arthritis. Traditionally, they have been large-scale clues such as joint pain, swelling, and inflammation. But better technology is gradually moving the diagnostic hunt to the molecular level. New techniques are being developed that can scan your blood, determine which proteins are present and, based on the "protein signature" found, tell the doctor what type of arthritis you have, and which drugs will work best to relieve it.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access